These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21060876)

  • 21. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer.
    Li JN; Zhao L; Wu J; Wu B; Yang H; Zhang HH; Qian JM
    J Dig Dis; 2012 Jan; 13(1):24-32. PubMed ID: 22188913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional modules with disease discrimination abilities for various cancers.
    Yao C; Zhang M; Zou J; Li H; Wang D; Zhu J; Guo Z
    Sci China Life Sci; 2011 Feb; 54(2):189-93. PubMed ID: 21318490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of disease-specific genes in chronic pancreatitis using DNA array technology.
    Friess H; Ding J; Kleeff J; Liao Q; Berberat PO; Hammer J; Büchler MW
    Ann Surg; 2001 Dec; 234(6):769-78; discussion 778-9. PubMed ID: 11729383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
    Chang WH; Lai AG
    BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.
    Amatschek S; Koenig U; Auer H; Steinlein P; Pacher M; Gruenfelder A; Dekan G; Vogl S; Kubista E; Heider KH; Stratowa C; Schreiber M; Sommergruber W
    Cancer Res; 2004 Feb; 64(3):844-56. PubMed ID: 14871811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conservation of immune gene signatures in solid tumors and prognostic implications.
    Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
    BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of HapMap-based SNP pattern analysis and gene expression profiling reveals common SNP profiles for cancer therapy outcome predictor genes.
    Glinsky GV
    Cell Cycle; 2006 Nov; 5(22):2613-25. PubMed ID: 17172834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis.
    Liu BH; Goh CH; Ooi LL; Hui KM
    Oncogene; 2008 Jul; 27(29):4128-36. PubMed ID: 18332864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection.
    Schummer M; Green A; Beatty JD; Karlan BY; Karlan S; Gross J; Thornton S; McIntosh M; Urban N
    PLoS One; 2010 Feb; 5(2):e9122. PubMed ID: 20161755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling.
    Tackels-Horne D; Goodman MD; Williams AJ; Wilson DJ; Eskandari T; Vogt LM; Boland JF; Scherf U; Vockley JG
    Cancer; 2001 Jul; 92(2):395-405. PubMed ID: 11466695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.
    Kumar D; Hassan MK; Pattnaik N; Mohapatra N; Dixit M
    PLoS One; 2017; 12(10):e0186977. PubMed ID: 29073199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative survey of functional footprints of EGFR pathway mutations in human cancers.
    Lane A; Segura-Cabrera A; Komurov K
    Oncogene; 2014 Oct; 33(43):5078-89. PubMed ID: 24166508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.
    Fisher LW; Jain A; Tayback M; Fedarko NS
    Clin Cancer Res; 2004 Dec; 10(24):8501-11. PubMed ID: 15623631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
    Bild AH; Yao G; Chang JT; Wang Q; Potti A; Chasse D; Joshi MB; Harpole D; Lancaster JM; Berchuck A; Olson JA; Marks JR; Dressman HK; West M; Nevins JR
    Nature; 2006 Jan; 439(7074):353-7. PubMed ID: 16273092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues.
    Wang L; Yu J; Xu J; Zheng C; Li X; Du J
    Gene; 2015 Jan; 554(1):1-8. PubMed ID: 25452192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
    Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
    BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
    Hansel DE; Rahman A; Hidalgo M; Thuluvath PJ; Lillemoe KD; Schulick R; Ku JL; Park JG; Miyazaki K; Ashfaq R; Wistuba II; Varma R; Hawthorne L; Geradts J; Argani P; Maitra A
    Am J Pathol; 2003 Jul; 163(1):217-29. PubMed ID: 12819026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of clinical cancer management: one tumor, one chip.
    Yeatman TJ
    Am Surg; 2003 Jan; 69(1):41-4. PubMed ID: 12575779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.